Thrombospondin-1 (TSP-1) is a naturally occurring inhibitor of angiogenesis
that limits vessel density in normal tissues and curtails tumor growth. He
re, we show that the inhibition of angiogenesis in vitro and in vivo and th
e induction of apoptosis by thrombospondin-1 all required the sequential ac
tivation of CD36, p59(fyn), caspase-3 like proteases and p38 mitogen-activa
ted protein kinases. We also detected increased endothelial cell apoptosis
in situ at the margins of tumors in mice treated with thrombospondin-1. The
se results indicate that thrombospondin-1, and possibly other broad-spectru
m natural inhibitors of angiogenesis, act in vivo by inducing receptor-medi
ated apoptosis in activated microvascular endothelial cells.